Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Sep;74(9):812-814.
doi: 10.1016/j.recesp.2021.03.009. Epub 2021 Mar 20.

[Acute myocarditis after administration of the BNT162b2 vaccine against COVID-19]

[Article in Spanish]
Affiliations
Case Reports

[Acute myocarditis after administration of the BNT162b2 vaccine against COVID-19]

[Article in Spanish]
Javier Bautista García et al. Rev Esp Cardiol. 2021 Sep.
No abstract available

PubMed Disclaimer

Figures

Figura 1
Figura 1
A: electrocardiograma en ritmo sinusal con descenso del intervalo PR en I y V5-V6 y elevación del segmento ST con concavidad superior de forma difusa. B: electrocardiograma en ritmo sinusal con elevación < 1 mm y convexidad superior en V3-V6 y negativización de ondas T en I, II, aVL y V3-V6.
Figura 2
Figura 2
Resonancia magnética con realce tardío en la región lateral mediodistal y edema en las secuencias potenciadas en T2-STIR.

References

    1. Su J.R., McNeil M.M., Welsh K.J., et al. Myopericarditis after vaccination, vaccine adverse event reporting system (VAERS), 1990-2018. Vaccine. 2021;39:839–845. - PubMed
    1. Mele D., Flamigni F., Rapezzi C., et al. Myocarditis in COVID-19 patients: current problems. Intern Emerg Med. 2021 doi: 10.1007/s11739-021-02635-w. - DOI - PMC - PubMed
    1. Salamanca J., Díez-Villanueva P., Martínez P., Cecconi A., et al. COVID-19 “fulminant myocarditis” successfully treated with temporary mechanical circulatory support. JACC Cardiovasc Imaging. 2020;13:2457–2459. - PMC - PubMed
    1. Talotta R. Do COVID-19 RNA-based vaccines put at risk of immune-mediated diseases? In reply to “Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases”. Clin Immunol. 2021;224:108665. - PMC - PubMed
    1. Polack F.P., Thomas S.J., Kitchin N., et al. Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine. N Engl J Med. 2020;383:2603–2615. - PMC - PubMed

Publication types

LinkOut - more resources